During the past decade, Caro Cancer Center conducted 107 clinical trials. In the 10-year time frame, 107 clinical trials started and 30 clinical trials were completed, i.e. on average, 28% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 29 clinical trials were completed. i.e. 111.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Caro Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 62 trials, followed by "Alliance for Clinical Trials in Oncology" with 27 trials sponsored, "SWOG Cancer Research Network" with 19 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored and "NRG Oncology" with 12 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Caro Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 69 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Caro Cancer Center" are "Stage IV Lung Cancer AJCC v8" (8 trials), "Invasive Breast Carcinoma" (5 trials), "Recurrent Lung Non-Small Cell Carcinoma" (5 trials), "Stage IIIB Lung Cancer AJCC v8" (5 trials) and "Stage IV Breast Cancer AJCC v6 and v7" (5 trials). Many other conditions were trialed in "Caro Cancer Center" in a lesser frequency.

Most popular intervention types in "Caro Cancer Center" are "Drug" (105 trials), "Other" (78 trials), "Biological" (51 trials), "Procedure" (37 trials) and "Radiation" (12 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (38 trials), "Laboratory Biomarker Analysis" (28 trials), "Questionnaire Administration" (25 trials), "Biospecimen Collection" (23 trials) and "Computed Tomography" (23 trials). Other intervention names were less common.

The vast majority of trials in "Caro Cancer Center" are 115 trials for "All" genders, 15 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Caro Cancer Center". undefined are not yet recruiting, 48 are recruiting, 61 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Caro Cancer Center, 6 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Caro Cancer Center, 2 "Phase 1" clinical trials were conducted, 67 "Phase 2" clinical trials and 69 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".